Clinical Trial Update: Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of the investigational drug PF04937319 in patients with Type 2 Diabetes Mellitus; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF04937319

Snippet

Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2017-01-31